• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Clinical trial of intrapleural administration of gelatin-embedded, sustained-release basic fibroblast growth factor for the regeneration of emphysematous lungs

Research Project

Project/Area Number 15K10269
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Respiratory surgery
Research InstitutionWakayama Medical University

Principal Investigator

Kawago Mitsumasa  和歌山県立医科大学, 医学部, 講師 (50644093)

Co-Investigator(Kenkyū-buntansha) 田畑 泰彦  京都大学, ウイルス・再生医科学研究所, 教授 (50211371)
吉増 達也  和歌山県立医科大学, 医学部, 准教授 (60316099)
Research Collaborator Tabata Yasuhiko  京都大学, ウイルス・再生医科学研究所, 教授 (50211371)
Yoshimasu Tatsuya  和歌山県立医科大学, 医学部, 准教授 (60316099)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords肺気腫 / 再生医療 / basic-FGF / Drug delivery system / 気胸 / ドラッグデリバリーシステム
Outline of Final Research Achievements

The prognosis of patients with pneumothorax combined with pulmonary emphysema is poor due to destruction of the lung. We reported that intrapleural administration of gelatin-embedded, sustained-release basic fibroblast growth factor induced lung regeneration in an elastase-induced pulmonary emphysema model in rats.Phase II clinical trial was performed to lung regeneration with sustained-release basic fibroblast growth factor for the purpose of closing fistula and preventing recurrence.
Fifteen pneumothorax patients with advanced pulmonary emphysema were enrolled. In all cases, air leakage were stopped and there were no serious side effects.
The effect of regeneration was evaluated by the ratio of the low attenuation area of chest CT (LAA%). LAA% decreased significantly from 46.8 ± 20.9% before treatment to 32.3 ± 20.5% after treatment (p=0.0215).It was suggested that intrapleural administration of sustained-release basic fibroblast growth factor induced lung regeneration.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (3 results)

All 2017 2015

All Presentation (2 results) Book (1 results)

  • [Presentation] 徐放化basic-FGF製剤の胸腔内投与による肺気腫の再生医療2017

    • Author(s)
      吉増達也、木下貴裕、田畑泰彦、山本雅哉、川後光正、平井慶充 、大橋拓矢、矢田由美、房本安矢、尾浦正二、宮坂美和子、青石裕香、西口春香、西村好晴
    • Organizer
      第33回日本DDS学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] 徐放化b-FGF製剤の胸腔内投与による肺気腫の再生医療:肺胞再生の可能性について.2015

    • Author(s)
      吉増達也, 尾浦正二, 粉川庸三, 川後光正, 宮坂美和子, 大橋拓矢, 青石裕香, 清井めぐみ, 西口春香, 本田麻里子, 岡村吉隆, 木下貴裕, 山本雅哉, 田畑泰彦.
    • Organizer
      第32回日本呼吸器外科学会総会
    • Place of Presentation
      高松
    • Year and Date
      2015-05-14
    • Related Report
      2015 Research-status Report
  • [Book] Annual Review 2015 呼吸器2015

    • Author(s)
      吉増達也
    • Total Pages
      252
    • Publisher
      中外医学社
    • Related Report
      2015 Research-status Report

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi